OLIPASS Corporation (KOSDAQ:244460)
South Korea
· Delayed Price · Currency is KRW 1,651.00
-267.00 (-13.92%)
At close: Apr 7, 2025
OLIPASS Revenue
OLIPASS had revenue of 1.81B KRW in the quarter ending September 30, 2023, with 811.99% growth. This brings the company's revenue in the last twelve months to 5.25B, up 190.70% year-over-year. In the year 2022, OLIPASS had annual revenue of 2.30B with 169.56% growth.
Revenue (ttm)
5.25B
Revenue Growth
+190.70%
P/S Ratio
1.60
Revenue / Employee
67.32M
Employees
78
Market Cap
8.40B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Angiolab | 702.62M |
| Femtobiomed | 389.96M |
| Genotech | 7.28B |
| The Technology | 8.75B |
| Moogene Medi | 12.95M |
| MOA Life Plus | 9.80B |
| ADBiotech | 14.57B |
| Epibiotech | 449.62M |